LINK: Preliminary Programme – SDIR-7 (PDF)
Scientific Programme
Wednesday, October 08, 2025
12.00 – 13.00 Registration and Networking over light lunch
13.00 – 13.30 Opening Ceremony
SDIR, HDIR and MOKAD Presidents
Minister of Health of the Republic of Serbia
Minister of Science, Technological Development, and Innovations of the Republic of Serbia
Acting Director of the Institute for Oncology and Radiology of Serbia
Dr Mirjana Mihailović, Director of the Institute for Biological Research “Siniša Stanković”, University of Belgrade, Serbia
Dr Milica Pešić, Dr Neda Slade, Dr Sergi Castellvi-Bel, SHM1RC Scientific Committee Chairs
Dr Ana Damjanović Veličković, Dr Petar Ozretić, SHM1RC Organizing Committee Chairs
13.30 – 14.45 Session 1: Benefits of the Combination Therapies in Cancer Treatment
Chairs: Ivana Matić and Vesna Vučić
Invited Lecture 1
Orcun Can (Turkey), Department of Medical Oncology, University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital, Istanbul,
Title: Benefits of Combination Therapies in Cancer Treatment (15`)
Discussion 5’
Invited Lecture 2
Katalin Hideghéty (HU), Department of Oncotherapy at the University of Szeged
Title: Novel Approaches in Radiation Oncology with a Special Focus on Combination Therapies (15`)
Discussion 5’
Invited Lecture 3
Zorica Cvetković (Serbia), Clinical Hospital Center Zemun, Faculty of Medicine, University of Belgrade
Title: Benefits of combination therapies in the treatment of haematological malignancies (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
14.45 – 16.00 Session 2: Personalized Anticancer Treatment through Targeting Signaling Pathways
Chairs: Neda Slade and Ana Đurić
Invited Lecture 1
Omer Faruk Bayrak (Turkey), Yeditepe University. Istanbul
Title: The Importance of Tumor Typing for Cancer Patients and Future Perspectives of Molecular Biology of Cancer (15`)
Discussion 5’
Invited Lecture 2
Anamaria Brozović (Croatia), Ruder Boskovic Institute, Zagreb
Title: Manipulation of genes involved in both drug resistance and drug-induced EMT reveals unpredictable ovarian cancer cell morphology and stress (15`)
Discussion 5’
Invited Lecture 3
Nevena Gajević (Serbia), Faculty of Medical Sciences, Kragujevac
Title: The role of antidiabetics on growth and progression of breast cancer by modulating antitumor immunity (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
16.00 – 17.00 Coffee break & poster viewing 1 (20 abstracts) & Projects Hub
17.00 – 18.00 Session 3: Tumor Microenvironment – Friend or Foe
Chairs: Jelena Grahovac and Andrei Turtoi
Invited Lecture 1
Andrei Turtoi (France), French Institute of Health and Medical Research, Paris (Inserm)
Title: Cancer-associated fibroblast spatial heterogeneity (15`)
Discussion 5’
Invited Lecture 2
Lazar Vujanović (USA), University of Pittsburgh, PA
Title: Immune cell dynamics associate with response to neoadjuvant cancer immunotherapies (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
18.00 – 19.00 Session 4: Immunooncology
Chairs: Ana Vuletić and Milica Perišić Nanut
Invited Lecture 1
Ivan Jovanović (Serbia), Faculty of Medical Sciences, Kragujevac
Title: Dual blockage of PD-L/PD-1 and IL33/ST2 axes as a potential antitumor therapy (15`)
Discussion 5’
Invited Lecture 2
Milica Perisic Nanut (Slovenia), Jozef Stefan Institute, Ljubljana
Title: TBD (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
19.00 Day One Conclusion & Networking
Thursday, October 09, 2025
09.00 – 10.15 Session 5: Exploring the Role of MDR Mechanisms and Stem Cell Biology in Cancer and Cancer Treatment Strategies
Chairs: Jelena Milašin and Gergely Szakacs
Invited Lecture 1
Katalin Goda (Hungary), University of Debrecen, Debrecen
Title: Multidrug resistance – poly-specific drug recognition by ABC transporters (15`)
Discussion 5’
Invited Lecture 2
Miloš Lazarević (Serbia), School of Dental Medicine, University of Belgrade
Title: Eliminating Oral Cancer Stem Cells by Targeting Oncogenic miR-21 and BET-Mediated Transcription (15`)
Discussion 5’
Invited Lecture 3
Tanja Matijević Glavan (Croatia), Rudjer Boskovic Institite, Zagreb
Title: The role of ufmylation in head and neck cancer stem cells (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
10.15 – 11.15 Session 6: Cancer Epidemiology: Strategies for Prevention and Early Detection
Chairs: Ana Krivokuća and Sergi Castellvi-Bel
Invited Lecture 1
Sergi Castellvi-Bel (Spain), August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona
Title: Genetic predisposition to gastrointestinal cancer (15`)
Discussion 5’
Invited Lecture 2
Ivana Božović Spasojević (Serbia), Institute for Oncology and Radiology of Serbia, Belgrade
Title: Adjuvant therapy options for patients with germline BRCA1/2 mutations (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
11.15 – 12.15 Coffee break & poster viewing 2 (20 abstracts) & Projects Hub
12.15 – 13.30 Session 7: Advancements in Molecular Diagnostics and Cancer Biomarkers in Oncology
Chairs: Radmila Janković, Vesna Ćorić, and Petar Ozretić
Invited Lecture 1
Ellora Sen (India), National Brain Research Centre, Manesar, Haryana, India
Title: Exploring the Metabolic Landscape of IDH-Mutant Gliomas for Therapeutic Intervention (15`)
Discussion 5’
Invited Lecture 2
Vesna Musani (Croatia), Rudjer Boskovic Institite, Zagreb
Title: The (first) 20 years of BRCA testing in Croatia (15`)
Discussion 5’
Invited Lecture 3
Marijana Milovic Kovacevic (Serbia), Institute for Oncology and Radiology of Serbia, Belgrade
Title: Homologous recombination deficiency-based therapeutic strategies in ovarian cancer (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
13.30 – 14.30 Lunch
14.30 – 15.45 Session 8: Liquid Biopsy (EACR Plenary Session)
Chairs: Evi Lianidou and Milena Čavić
Plenary Lecture 1
Evi Lianidou (EACR), National and Kapodistrian University of Athens, Greece
Title: Comprehensive liquid biopsy tumor analysis using circulating tumor cells (30`)
Discussion 10’
Invited Lecture
Berkcan Dogan (MOKAD), affiliation
Title: Novel miRNA Signatures as Potential Biomarkers for Circulating Tumor Cell Status in Metastatic Colorectal Cancer (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
15.45 – 16.45 Session 9: Clinical Oncology – Bridging Patients and Researchers
Chairs: Jelena Spasić and Bojana Cikota-Aleksić
Plenary Lecture 2
Karen-Lise Germ-Spindler (Denmark), Aarhus University Hospital, Aarhus University
Title: ctDNA-Response evaluation criteria in solid tumors – significance for monitoring of patient outcomes (25`)
Discussion 5’
Patient-clinician-scientist educational interactive panel (30`)
16.45 – 17.45 Coffee break & poster viewing 3 (20 abstracts) & Projects Hub
17.45 – 19.15 Session 10: Meet the Experts
Chairs: Katarina Zeljić and Aleksandra Nikolić
19.15 Day Two Conclusion
20.00 Networking Event
Friday, October 10, 2025
09.00 – 10.15 Session 11: Bioinformatics and Cancer Genomics
Chairs: Thomas Mohr, Nina Petrović, and Ömer Faruk Bayrak
Invited Lecture 1
Sema Misir (Turkey), Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas
Title: CircRNA-miRNA interactions and bioinformatics analysis in cancer (15`)
Discussion 5’
Invited Lecture 2
Verena Paulitschke (Austria), Medical University of Vienna
Title: Proteomic and metabolomics profiling of advanced melanoma patients to predict and monitor the therapeutic response to immune therapy (15`)
Discussion 5’
Invited Lecture 3
Miodrag Dragoj (Serbia), Institute for Biological Research “Siniša Stanković” – National Institute of Republic of Serbia, University of Belgrade
Title: Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung Cancer (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
10.15 – 11.30 Session 12: Novel Cancer Therapies and Drug Development Strategies
Chairs: Konstantinos Dimas, Ellora Sen, and Aleksandra Nikolić
Invited Lecture 1
Árpád Szöőr (Hungary), University of Debrecen
Title: CART cell therapy: a global perspective with a focus on Hungary’s journey (15`)
Discussion 5’
Invited Lecture 2
Marijeta Kralj (Croatia), Rudjer Boskovic Institite, Zagreb
Title: Targeting Multidrug Resistance and Cancer Stem Cells with Ionophores (15`)
Discussion 5’
Invited Lecture 3
Dijana Bovan (Serbia), Institute for Biological Research “Siniša Stanković” – National Institute of Republic of Serbia, University of Belgrade
Title: Dual targeting concept: hybrid molecules of cisplatin and antiinflammatory drugs (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
11.30 – 12.30 Coffee break & poster viewing 4 (20 abstracts) & Projects Hub
12.30 – 13.30 Session 13: Toxic Triggers: Environmental Chemicals and Cancer Risk
Chairs: Aleksandra Buha Djordjevic and Serap Celikler
Invited Lecture 1
Ayşegül Çebi (Turkey), Faculty of Health Sciences, Giresun University
Title: Acrylamide in food and its carcinogenic potential: What do we really know? (15`)
Discussion 5’
Invited Lecture 2
Janoš Terzić (Croatia), University of Split, School of Medicine
Title: Role of microbiota in bladder carcinogenesis (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
13.30 – 14.30 Lunch
14.30 – 15.45 Session 14: Tumor Metabolism
Chairs: Sandra Sobočanec, Busra Kose Demirtas and Alexey Bogdanov
Invited Lecture 1
Büşra Kose Demirtas (Turkey), Medical Faculty, Istinye University, Istanbul
Title: Tumor metabolism in the picture: tracing and visualizing the metabolic alterations in cancer (15`)
Discussion 5’
Invited Lecture 2
Alexey Bogdanov (Russia), Oncocentre GBUZ “SPb KNTsSVMP(o) named after N.P.. Napalkova”
Title: Changes in tumor metabolism, consequences, and therapeutic opportunities (15`)
Discussion 5’
Invited Lecture 3
Ana Čipak Gašparović (Croatia), Ruđer Bošković Institute, Zagreb
Title: Interplay between redox regulation and cancer metabolism (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
15.45 – 17.00 Session 15: Innovative Models and Approaches in Cancer Research
Chairs: Maja Sabol, Sedef Ziyanok, and Danijela Maksimović-Ivanić
Invited Lecture 1
Inga Urlić (Croatia), University of Zagreb, Faculty of Science
Title: Tracking Osteosarcoma Progression: A Longitudinal Single-Patient Study Integrating Functional Analyses and Single-Cell Transcriptom (15`)
Discussion 5’
Invited Lecture 2
Ivan Ranđelović (Hungary), National Institute of Oncology, Budapest
Title: PDTX models (15`)
Discussion 5’
Invited Lecture 3
Melita Vidaković (Serbia), Institute for Biological Research “Siniša Stanković” – National Institute of Republic of Serbia, University of Belgrade
Title: Targeted rewriting of epigenetic markers as a new therapuetic approach in triple negative breast cancer (15`)
Discussion 5’
Oral presentations selected from abstracts 2×5’
Discussion 5’
16.45 – 17.15 Coffee break & Projects Hub
17.15 – 18.45 Session 16: Strengthening Regional Collaboration
Chairs: Milica Pešić, Sonja Levanat and Makis Zoidakis
Invited Lecture 1
Engin Ulukaya (Turkey), Medical Faculty, Istinye University, Istanbul
Title: Palladium-based anticancer compounds in cancer treatment: A new hope or not? (15`)
Discussion 5’
Invited Lecture 2
Sandra Sobočanec (Croatia), Ruđer Bošković Institute, Zagreb
Title: From Tumor Suppression to Stress Response: The Diverse Roles of Sirtuin 3 in Cancer and Sex-Dependent DNA Damage Adaptation (15`)
Discussion 5’
Invited Lecture 3
Ivana Matić (Serbia), Institute for Oncology and Radiology of Serbia
Title: Investigation of individual radiosensitivity of prostate cancer patients under radiation treatment (15`)
Discussion 5’
Interactive panel on regional collaboration (30`)
18.45- 19.00 Award Ceremony
EACR-sponsored Best Abstract Awards
FEBSOpenBio Award for Best Abstract Award
SDIR-sponsored Best Student Poster Award and Annual acknowledgements for scientific excellence
19.00 Congress conclusions & networking
20.00 Networking Event
Saturday, October 11, 2025
11.00 – 14.00 Guided Tour